Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 CPT code 19283

Percutaneous placement of a breast localization device (e.g., clip, pellet, wire, seeds) for the first lesion, using stereotactic guidance.

Follow CPT guidelines and payer-specific guidelines for appropriate coding and billing practices. Pay close attention to the use of modifiers.

Modifiers 26 (professional component), TC (technical component), and 50 (bilateral procedure) may be applicable depending on the billed services and the circumstances.

Medical necessity is established based on the presence of a suspicious breast lesion requiring precise localization for biopsy or surgical excision.Supporting documentation should demonstrate the clinical need for the procedure and the appropriateness of the selected device and method.

The physician or qualified healthcare professional is responsible for pre-procedural assessment, image guidance, percutaneous device placement, and post-procedural care, including image confirmation of device placement and wound closure.In some settings, technical components such as equipment and staff may be handled by a facility.

IMPORTANT:19281, 19282, 19284, 19285, 19286, 19287, 19288 are related codes for placement of breast localization devices, with variations based on the lesion number, imaging modality and laterality.If an open biopsy follows, the localization code may also be reported. Add-on codes may be used for multiple localization device placements with the same imaging modality.

In simple words: This code describes a procedure where a small marker is placed in the breast to pinpoint an abnormal area before a biopsy or surgery.A doctor uses imaging to guide a small needle to precisely place the marker, making the abnormal area easier to find later.

This CPT code encompasses the percutaneous placement of a breast localization device (e.g., clip, metallic pellet, wire/needle, or radioactive seeds) for the first lesion identified in the breast.The procedure involves using stereotactic guidance to precisely locate the lesion and then percutaneously inserting the localization device to mark its location.Stereotactic guidance is inherently included in the code and should not be billed separately. The device placement facilitates subsequent biopsy or surgical procedures by accurately identifying the target tissue.

Example 1: A 45-year-old female presents with a suspicious mammographic finding.The radiologist performs a stereotactic breast biopsy, placing a localization clip (code 19283) percutaneously before the biopsy to precisely target the lesion., A 60-year-old female undergoes ultrasound-guided core needle biopsy.Prior to the biopsy, the radiologist uses ultrasound guidance to place a localization wire (code 19283) to mark the target location., A 52-year-old female has a palpable breast mass.A surgeon utilizes a wire localization (code 19283) technique to mark the lesion prior to surgical excision.

* Detailed clinical history including reason for the procedure.* Imaging reports (mammography, ultrasound, etc.) showing the lesion location.* Images documenting device placement.* Operative report if the procedure is followed by a biopsy or surgical intervention.* Pathology report if a biopsy is performed.

** The selection of a specific code (19281-19288) depends on factors like the number of lesions, laterality, and imaging modality used.Always refer to the most up-to-date CPT codebook and payer guidelines for accurate coding and billing.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.